Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03106844 · ClinicalTrials.gov registry record · Phase 1
The ICON Study: Outcomes After FMT for Patients With IBD and CDI
A Phase 1 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
NCT03106844 is a Phase 1 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 50 participants.
The verdict
NCT03106844, a Phase 1 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
In this study the investigators will evaluate patients with IBD and and at least 2 confirmed c.difficile infections who will be undergoing FMT. The investigators will assess patients before FMT and then follow patients prospectively post FMT at week 1, 8 and 12 to assess for recurrence of c.difficile infection and IBD outcomes.
Interventions
- DRUG Fecal Microbiota Transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2020-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03106844
The ClinicalTrials.gov registry entry for NCT03106844 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fecal Microbiota Transplantation is the first listed.
NCT03106844 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03106844 about?
NCT03106844 is a clinical study titled "The ICON Study: Outcomes After FMT for Patients With IBD and CDI". In this study the investigators will evaluate patients with IBD and and at least 2 confirmed c.difficile infections who will be undergoing FMT. The investigators will assess patients before FMT and then follow patients prospectively post FMT at week 1, 8 and 12 to assess for recurrence of c.difficil...
What is the current status of trial NCT03106844?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2017-08-01. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03106844?
The interventions under investigation include: Fecal Microbiota Transplantation (DRUG).
Who is sponsoring clinical trial NCT03106844?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.